期刊文献+

胃癌中cyclin D1、cyclin E和P27的表达及其意义 被引量:6

EXPRESSION AND SIGNIFICANCE OF CYCLIN D1, CYCLINE AND P27 IN GASTRIC CARCINOMAS
下载PDF
导出
摘要 目的探讨cyclinD1、cyclinE和p27蛋白在胃癌中的表达及其意义。方法用免疫组化法检测60例胃癌组织中 cyclin D1、cyclin E和 p27蛋白的表达。结果胃癌组织中 cyclin D1、cyclin E和 p27蛋白表达阳性率分别为41.7%(25/60)、38.3%(23/60)和 36.7%(22/60);cyclin D1在胃癌中的表达与肿瘤 Lauren分型相关,cyclin E在胃癌中的表达与肿瘤分化程度、浸润深度及肿瘤分期相关,而p27蛋白的表达与肿瘤浸润深度、淋巴结转移和肿瘤分期相关。另外,cyclin E和 p27蛋白在胃癌中的表达呈现显著负相关。结论检测胃癌组织中cyclin D1、cyclin E和 p27蛋白的表达有助于判断肿瘤的进展程度。 Objective To study the expression and its significance of cyclin D1,cyclin E and p27 protein in gastric carcinoma. Methods The expression of cyclin D1,cyclin E and p27 protein in 60 cases of gastric carcinoma were detected by immunostaining method. Results The positive rates of cyclin D1, cyclin E and p27 protein expression in gastric carcinoma were 41. 7% (25/60), 38. 3 % (23/60) and 36. 7 % (22/60), respectively. The expression of cyclin D1 was significantly correlated with Lauren type of tumor, the expression of cyclin E was significantly correlated with tumor differentiation, infiltration and stage, while the expression of P27 protein was significantly correlated with tumor infiltration,lymph nodes metastasis and stage. Further more, the expression of cyclin E was inversely correlated with the expression of p27. Conclusion Detection of cyclin D1,cyclin E and p27 expression in gastric carcinoma may be helpful in determining tumor progression.
出处 《中国普外基础与临床杂志》 CAS 2001年第3期148-150,共3页 Chinese Journal of Bases and Clinics In General Surgery
基金 江苏省科委科研项目(BS99317)
关键词 胃癌 细胞周期蛋白D1 细胞周期蛋白E P27蛋白 免疫组织化学 Gastric carcinoma Cyclin D1 Cyclin E p27 protein Immunohistochemistry
  • 相关文献

参考文献6

  • 1[1]Lazzereschi D,Sanbuco L,Scalzo CC,et al.Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas [J]. Int J Cancer,1998; 76(6)∶806 被引量:1
  • 2[2]Muller W,Noguchi T,Wirtz HC,et al.Expression of cell-cycle regulatory proteins cyclin D1,cyclin E,and their inhibitor p21 waf 1/cip 1 in gastric cancer [J]. J Pathol,1999; 189(1)∶186 被引量:1
  • 3[3]Kim SJ,Lee JB,Kim CS,et al.Cyclin D1 and p21 expression in gastric adenocarcinoma [C].3rd. International Gastric Cancer Congress, 1999∶359~360 被引量:1
  • 4[4]Yasui W,Akama Y,Kuniyasu H,et al.Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status [J]. J Exp Ther Oncol,1996; 1(1)∶88 被引量:1
  • 5[5]Yasui W,Kudo Y,Semba S,et al.Reduced expression of cyclin-dependent kinase inhibitor p27 kip1 is associated with advanced stage and invasiveness of gastric carcinomas [J].Jpn J Cancer Res,1997; 88(7)∶625 被引量:1
  • 6[6]Fredersdorf S,Burns J,Milne AM,et al.High level expression of p27 kip1 and cyclin D1 in some human breast cancer cells:inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancers [J].Proc Natl Acad Sci USA,1997; 94(12)∶6380 被引量:1

同被引文献36

  • 1Lloyd RV, Erickson LA, Jin L, et al. p27^KIPI, a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers [J]. Am J Pathol, 1999; 154(2) :313. 被引量:1
  • 2Peng D, Fan Z, Lu Y, et al. Anti-epidexmal growth factor receptor monoclonal antibody 225 up-regulates p27^KIPI and induces G1 arrest in prostatic cancer cell line DU145^1 [J]. Cancer Res, 1996; 56(16) : 3666. 被引量:1
  • 3Polyak K, Kato JY, Solomon MJ, et al. p27^KIPI , a cyclin-CDK inhibitor; links transforming growth factor-beta and contact inhibition to cell cycle arrest [J]. Genes Dey, 1994; 8(1) : 9. 被引量:1
  • 4Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclin-dependent kinase inhibitor p27^KIPI is a novel prognostic factor in localized human prostate adenocarcinoma [J]. Cancer Res, 1998; 58(3) : 542. 被引量:1
  • 5Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kipl in human malignancies [J]. Cancer Res, 1995, 55(11) : 2266. 被引量:1
  • 6Zhang Y, Lin SC. Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter [J]. Biochim Biophys Acta,1997, 1353(3) :307. 被引量:1
  • 7Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas [J]. Nat Med, 1997; 3(2) :231. 被引量:1
  • 8Ito Y, Matsuura N, Sakon M, et al. Expression and prognostic roles of the Gt-S Modulators in hepatocellular carcinoma: p27 independently predicts the recurrence [J]. Hepatology, 1999, 30(1) : 90. 被引量:1
  • 9Sgambato A, Cittadini A, Faraglia B, et al. Multiple functions of p27kipl and its alterations in tumor cells: A review [J]. J Cell Physio,2000,183(1) : 18. 被引量:1
  • 10Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitinproteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 [J]. Science, 1995, 269(5224) : 682. 被引量:1

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部